Between studies and experiments, which will keep India’s Shubanshu Shukla and other astronauts on the Axiom-4 mission, busy during their two-week stay in space, to expect to be launched on 10 June, aims to enable diabetics to travel in space.
So far, insulin-dependent diabetic patients are not chosen to become astronauts. This is because the space atmosphere, especially microscopic conditions, make the blood sugar levels control and difficult to maintain. But scientists around the world have been working for the last several years to make it possible.
A diabetes related research project on the Axiom-4 mission is an important step in that attempt.
One or more astronauts on the mission-it is not disclosed who they can be-will wear a continuous glucose meter (CGM) during their stay in the space, and their real-time blood sugar measurement will be monitored by the research team on Earth.
They will also collect blood samples during their flight, which can later be tested to validate CGM readings.
The mission will also take two varieties of insulin pen: one refrigerant, another in ambient air conditions. They will investigate whether their integrity is intact in subtle gravitational conditions.
“One of the primary objectives of the study is collected data that is relevant for diabetes to make the space journey possible. But this is not just that. Research can also be helpful to the management of diabetes on Earth,” described the Indian Express in an interview, “the Dubai-based diagnostic lead for this research project, called a suit ride, described the Indian Express in an interview.
The story continues below this advertisement
Fighton is the Chief Medical Officer in Burjel Medical City, a hospital in Dubai, who is collaborating with a self -proclaimed place for this research project.
Diabetes research is not new in space. The study on this has been going on for many years. Even the CGM is first worn by astronauts. Astronaut, a private mission on the Polaris Dawn Mission, who stayed in space for five days in September last year, wore CGMS. But it was limited to collecting blood sugar data while in space.
Last year, Galactic 07 Mission, a sub-orbital flight operated by Virgin Galactic, was first displayed that commercially available insulin pen can be used to effectively distribute hormones in space.
Fighton stated that the study on the Axiom-4 mission is a more “well round effort” on diabetes research in space.
The story continues below this advertisement
“Real -time measurement of blood sugar, recognition of CGM, and an assessment of whether insulin maintains its viability and integrity in space … These are things that have never been done before,” Fighton said.
“The study will continue for two weeks of the mission. This is still a short-term study. We will not be able to monitor blood sugar levels over the long term. But even this data is very important to understand the effects of zero-gurutuction on diabetes.
Fighton said that research was also relevant to diabetics on Earth. “For example, previous studies at the International Space Station have shown that the effect of microgravity leads to fluid changes in astronauts. Such a situation is similar to patients running on long -term beds, whose movement has been severely banned. The data we are expecting to receive the self -respecting -4 mission can be very helpful in improving diabetes on earth.”
“Then the data is likely to throw some unexpected insights that can give rise to secondary results. Such a thing is all the time in scientific research,” he said.
,
